Melatonin Receptors

Melatonin receptor ligands act on melatonin receptors 1 and 2 (MT1, MT2), which mediate circadian signaling. Both are G protein-coupled receptors that respond to melatonin released by the pineal gland at night. MT1 was cloned in 1994 and linked to reproductive and circadian responses, and MT2 was characterized a year later in human retina and brain. The section lists melatonin itself and the agonists ramelteon, tasimelteon and agomelatine hydrochloride. It also includes luzindole, an MT1 and MT2 antagonist used to block receptor signaling in experiments, and ramelteon metabolite M-II.

1 Item

  • UCM 549
    Cat. No.
    A61729

    UCM 549

    UCM 549 is an inverse agonist of the melatonin MT2 receptor and an antagonist of the MT1 receptor. This compound modulates melatonin signaling pathways, making it a valuable tool for investigating sleep disorders and circadian rhythm regulation. Its application extends to studies focused on the role of melatonin receptors in neuroprotection and mood regulation.

    25 mg
    $1,275.00
    All 1 sizes

1 Item

Added to your cart

View Cart Checkout

    Loading...